Medpace Holdings is a holding company. Through its subsidiaries, Co. is a global provider of clinical research-based drug and medical device development services. Co. provides a suite of services supporting the entire clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s clinical development services include medical department, clinical trial management, data-driven feasibility, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, main laboratory, central laboratory, bioanalytical laboratory, clinics and quality assurance. We show 33 historical shares outstanding datapoints in our coverage of MEDP's shares outstanding history.
Understanding the changing numbers of MEDP shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like MEDP versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching MEDP by allowing them to research MEDP shares outstanding history
as well as any other stock in our coverage universe. |
Free MEDP Email Alerts:
Video: Shares Outstanding Importance
